Metropolitan Life Insurance CO Allovir, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.15 - $3.64 $2,919 - $4,943	1,358 Added 78.0%	3,099 $6,000
Q2 2023 Aug 10, 2023	BUY	$3.17 - $5.82 $4,035 - $7,408	1,273 Added 272.01%	1,741 $5,000
Q1 2023 May 15, 2023	SELL	$3.94 - $7.05 $5,622 - $10,060	-1,427 Reduced 75.3%	468 $1,000
Q4 2022 Jun 14, 2023	BUY	$4.7 - $9.98 $6,706 - $14,241	1,427 Added 304.91%	1,895 $9.72 Million
Q3 2022 Jun 14, 2023	BUY	$4.13 - $8.79 $5,893 - $12,543	1,427 Added 304.91%	1,895 $15 Million
Q3 2022 Mar 30, 2023	SELL	$4.13 - $8.79 $351 - $747	-85 Reduced 4.29%	1,895 $14,000
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $7,826 - $16,657	1,895 New	1,895 $15,000
Q2 2022 Aug 11, 2022	SELL	$3.26 - $7.06 $6,454 - $13,978	-1,980 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$6.75 - $13.52 $10,206 - $20,442	1,512 Added 323.08%	1,980 $13,000
Q1 2022 Mar 30, 2023	SELL	$6.75 - $13.52 $41,418 - $82,958	-6,136 Reduced 75.6%	1,980 $13,000
Q1 2022 May 12, 2022	SELL	$6.75 - $13.52 $41,418 - $82,958	-6,136 Reduced 75.6%	1,980 $13,000
Q4 2021 Jun 21, 2023	BUY	$12.94 - $25.99 $98,965 - $198,771	7,648 Added 1634.19%	8,116 $105,000
Q4 2021 Mar 30, 2023	SELL	$12.94 - $25.99 $10,791 - $21,675	-834 Reduced 9.32%	8,116 $105,000
Q4 2021 Feb 15, 2022	SELL	$12.94 - $25.99 $10,791 - $21,675	-834 Reduced 9.32%	8,116 $105,000
Q3 2021 Jun 21, 2023	BUY	$16.97 - $25.06 $143,939 - $212,558	8,482 Added 1812.39%	8,950 $224,000
Q3 2021 Mar 30, 2023	SELL	$16.97 - $25.06 $13,219 - $19,521	-779 Reduced 8.01%	8,950 $224,000
Q3 2021 Nov 15, 2021	SELL	$16.97 - $25.06 $13,219 - $19,521	-779 Reduced 8.01%	8,950 $224,000
Q2 2021 Jun 21, 2023	BUY	$19.44 - $25.06 $180,033 - $232,080	9,261 Added 1978.85%	9,729 $192,000
Q2 2021 Mar 30, 2023	BUY	$19.44 - $25.06 $19,828 - $25,561	1,020 Added 11.71%	9,729 $192,000
Q2 2021 Aug 16, 2021	BUY	$19.44 - $25.06 $188,956 - $243,583	9,720 Added 108000.0%	9,729 $192,000
Q1 2021 Jun 26, 2023	BUY	$20.81 - $45.5 $171,495 - $374,965	8,241 Added 1760.9%	8,709 $204 Million
Q1 2021 Mar 30, 2023	BUY	$20.81 - $45.5 $66,612 - $145,645	3,201 Added 58.12%	8,709 $203,000
Q1 2021 May 14, 2021	SELL	$20.81 - $45.5 $114,434 - $250,204	-5,499 Reduced 99.84%	9 $204,000
Q4 2020 Jun 22, 2023	BUY	$23.94 - $46.81 $120,657 - $235,922	5,040 Added 1076.92%	5,508 $211,000
Q3 2020 Jun 26, 2023	BUY	$21.05 - $42.7 $106,092 - $215,208	5,040 Added 1076.92%	5,508 $151,000
Q3 2020 Mar 30, 2023	BUY	$21.05 - $42.7 $76,053 - $154,275	3,613 Added 190.66%	5,508 $151,000
Q3 2020 Nov 13, 2020	BUY	$21.05 - $42.7 $115,943 - $235,191	5,508 New	5,508 $151,000

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

Eco R1 Capital, LLC San Francisco, CA

11.3M
Shares

$4.97 Million
0.4% of portfolio
Octagon Capital Advisors LP New York, NY

11.2M
Shares

$4.93 Million
2.19% of portfolio
Siren, L.L.C. New York, NY

6.6M
Shares

$2.9 Million
0.27% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.28M
Shares

$1.45 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.65M
Shares

$1.16 Million
0.0% of portfolio

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account